For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...

Vibration plates are a trending fitness gadget promoted online for rapid results. Experts caution that these devices offer modest benefits,...

This is a market to be selective in, not brave in. The safer way to play a turn in the market is to stay with businesses whose demand does ...

Researchers from the University of Leipzig and Shandong University have recognized GPR133, a receptor in bone-forming cells, as significant...

This silent disease weakens men's bones, leading to fractures. Around 2 million men in the US have it. Another 16 million have early bone l...

Osteoporosis is a medical condition that causes the bones to become weak and brittle. It is caused by various factors such as aging, geneti...

The same study found that 1 in 4 women is diagnosed with osteoporosis.

A history of prior fracture is one of the strongest predictors of future fractures.

Approximately 200 mn people around the world are estimated to be affected by the disease.

Adequate sleep of 6-8 hours daily is also essential for the body to repair.

Osteoporotic bones become porous and weaker, increasing the risk of fractures.

New Delhi, March 29 (IANS) A new study has found that people in the city are at a high risk of suffering from brittle bones which can cause...

Osteoporosis is characterised by high bone loss and less production of bones, results in reduced bone density.

Under the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...

The authors suggest that this could be due to the vested interests of industry, advocacy organisations, and academia.